Shilei Ding
Affiliations: | Microbiology and Immunology | McGill University, Montreal, QC, Canada |
Google:
"Shilei Ding"Mean distance: (not calculated yet)
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Grunst MW, Qin Z, Dodero-Rojas E, et al. (2024) Structure and inhibition of SARS-CoV-2 spike refolding in membranes. Science (New York, N.Y.). 385: 757-765 |
| Benlarbi M, Ding S, Bélanger É, et al. (2024) Temperature-dependent Spike-ACE2 interaction of Omicron subvariants is associated with viral transmission. Mbio. e0090724 |
| Marchitto L, Chatterjee D, Ding S, et al. (2023) Humoral Responses Elicited by SARS-CoV-2 mRNA Vaccine in People Living with HIV. Viruses. 15 |
| Leonhardt SA, Purdy MD, Grover JR, et al. (2023) Antiviral HIV-1 SERINC restriction factors disrupt virus membrane asymmetry. Nature Communications. 14: 4368 |
| Tolbert WD, Chen Y, Sun L, et al. (2023) The molecular basis of the neutralization breadth of the RBD-specific antibody CoV11. Frontiers in Immunology. 14: 1178355 |
| Guenthoer J, Lilly M, Starr TN, et al. (2023) Identification of broad, potent antibodies to functionally constrained regions of SARS-CoV-2 spike following a breakthrough infection. Proceedings of the National Academy of Sciences of the United States of America. 120: e2220948120 |
| Ding S, Tolbert WD, Zhu H, et al. (2023) Piperidine CD4-Mimetic Compounds Expose Vulnerable Env Epitopes Sensitizing HIV-1-Infected Cells to ADCC. Viruses. 15 |
| Yaffe ZA, Ding S, Sung K, et al. (2023) Reconstruction of a polyclonal ADCC antibody repertoire from an HIV-1 non-transmitting mother. Iscience. 26: 106762 |
| Ding S, Tolbert WD, Zhu H, et al. (2023) Piperidine CD4-mimetic compounds expose vulnerable Env epitopes sensitizing HIV-1-infected cells to ADCC. Biorxiv : the Preprint Server For Biology |
| Tauzin A, Nicolas A, Ding S, et al. (2023) Spike recognition and neutralization of SARS-CoV-2 Omicron subvariants elicited after the third dose of mRNA vaccine. Cell Reports. 42: 111998 |